Delivery Order SPE2DB20D9329-SPE2DB25FZK96
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, represents a tactical purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, designated as a firm fixed-price delivery order, was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, valued at $16,249.95, was awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The contract does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,308.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on September 29, 2025, with an ultimate completion date of October 21, 2025, represents a specific pharmaceutical product fulfillment under the company's existing indefinite delivery contract with DLA. No...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with a firm fixed-price contract structure and ultimate completion date of September 17, 2025. The contract carries no set-aside designation, allowing the vendor to compete directly...
- The Defense Logistics Agency (DLA) awarded a $48,749.85 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, awarded on June 30, 2025, with an ultimate completion date of July 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $387,704.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on September 27, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at...
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge, IL. This award represents a firm fixed-price delivery order under the company's larger Indefinite Delivery Contract with the DLA, valued...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB25FZK96Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market while leveraging its small business status. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for comprehensive pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. Stelara, a biologic medication used to treat various immune-mediated conditions, represents one of the specialized pharmaceutical products within the broader portfolio of branded and generic prescription drugs, biologics, and medical consumables that DMS Pharmaceutical Group supplies to federal healthcare systems. The company has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent contract performance across diverse product categories spanning injections, specialty medications, and other medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.5k | 8/26/25 |